Health Care & Life Sciences » Biotechnology | GlycoMimetics Inc.

GlycoMimetics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,992.60
15,027.00
20,070.80
18.50
-
275.10
Cost of Goods Sold (COGS) incl. D&A
133.10
158.70
-
-
263.50
275.10
Gross Income
3,859.60
14,868.30
-
-
263.50
275.10
SG&A Expense
14,448.30
26,008.10
32,664.10
31,741.40
33,668.70
51,229.70
EBIT
10,588.70
11,139.80
12,784.80
31,913.50
33,932.30
51,504.80
Non Operating Income/Expense
17.80
18.20
-
-
-
-
Pretax Income
10,605.60
11,121.60
12,769.50
31,809.80
33,281.10
48,273.60
Consolidated Net Income
10,605.60
11,121.60
12,769.50
31,809.80
33,281.10
48,273.60
Net Income
10,605.60
11,121.60
12,769.50
31,809.80
33,281.10
48,273.60
Net Income After Extraordinaries
10,605.60
11,121.60
12,769.50
31,809.80
33,281.10
48,273.60
Net Income Available to Common
10,605.60
11,121.60
12,769.50
31,809.80
33,281.10
48,273.60
EPS (Basic)
0.56
0.60
0.67
1.50
1.13
1.18
Basic Shares Outstanding
18,782.00
18,452.30
19,010.60
21,256.30
29,395.80
41,044.60
EPS (Diluted)
0.56
0.60
0.67
1.50
1.13
1.18
Diluted Shares Outstanding
18,782.00
18,452.30
19,010.60
21,256.30
29,395.80
41,044.60
EBITDA
10,455.70
10,981.10
12,593.30
31,722.90
33,668.70
51,229.70
Non-Operating Interest Income
0.90
-
15.30
103.60
651.20
3,231.20

About GlycoMimetics

View Profile
Address
9708 Medical Center Drive
Rockville Maryland 20850
United States
Employees -
Website http://www.glycomimetics.com
Updated 07/08/2019
GlycoMimetics, Inc. operates as a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. The company was founded by Rachel K.